𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

✍ Scribed by López-Pousa, A; Losa, R; Martín, J; Maurel, J; Fra, J; Sierra, M; Casado, A; García del Muro, J; Poveda, A; Balañá, C

Book ID
109998851
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
107 KB
Volume
94
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential dose-dense doxorubicin and if
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas : A Phase II Trial by the Spanish Group for Research on Sarcomas (GEIS)
✍ Joan Maurel; Joaquín Fra; Antonio López-Pousa; Xavier García del Muro; Carmen Ba 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND Combinations of high‐dose ifosfamide (IF; 10–12 g/m^2^) plus doxorubicin (DX; 50–90 mg/m^2^) have been administered to patients with advanced soft tissue sarcoma (ASTS) in an attempt to improve therapeutic efficacy. Although these combination regimens appear to yield high